EP Patent

EP4615465A1 — Compositions and methods for producing circular polyribonucleotides

Assigned to Flagship Pioneering Innovations VI Inc · Expires 2025-09-17 · 1y expired

What this patent protects

The present disclosure relates, generally, to compositions and methods for producing, purifying, and using circular RNA.

USPTO Abstract

The present disclosure relates, generally, to compositions and methods for producing, purifying, and using circular RNA.

Drugs covered by this patent

Patent Metadata

Patent number
EP4615465A1
Jurisdiction
EP
Classification
—
Expires
2025-09-17
Drug substance claim
No
Drug product claim
No
Assignee
Flagship Pioneering Innovations VI Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.